Brief: Theratechnologies Reports Positive Results for Trogarzo IV Push Administration Study
Sept 22 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES ANNOUNCES POSITIVE RESULTS FOR TROGARZO®
IV
PUSH ADMINISTRATION STUDY
* THERATECHNOLOGIES INC - TMB-302 STUDY RESULTS DEMONSTRATE
THAT
THERE WAS NO DIFFERENCE IN PHARMACOKINETICS BETWEEN IV PUSH AND
IV INFUSION
* THERATECHNOLOGIES INC - NO SERIOUS ADVERSE EVENTS OBSERVED
IN
TROGARZO IV PUSH ADMINISTRATION STUDY
* THERATECHNOLOGIES INC - BASED ON TROGARZO IV PUSH
ADMINISTRATION
STUDY DATA, SBLA FILING PLANNED FOR Q4 2021
Source text for Eikon: ID:nGNXbQSgSK
Further company coverage: TH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process